Nuveen Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $537M | Buy |
6,244,931
+2,639,693
| +73% | +$227M | 0.15% | 116 |
|
|
2024
Q3 | $429M | Buy |
3,605,238
+86,242
| +2% | +$10.3M | 0.12% | 146 |
|
|
2024
Q2 | $502M | Sell |
3,518,996
-153,290
| -4% | -$21.9M | 0.15% | 120 |
|
|
2024
Q1 | $472M | Buy |
3,672,286
+525,211
| +17% | +$67.5M | 0.14% | 131 |
|
|
2023
Q4 | $326M | Sell |
3,147,075
-41,389
| -1% | -$4.28M | 0.1% | 170 |
|
|
2023
Q3 | $290M | Buy |
3,188,464
+22,982
| +0.7% | +$2.09M | 0.1% | 180 |
|
|
2023
Q2 | $256M | Buy |
3,165,482
+850,078
| +37% | +$68.8M | 0.09% | 184 |
|
|
2023
Q1 | $184M | Buy |
2,315,404
+933,614
| +68% | +$74.3M | 0.07% | 243 |
|
|
2022
Q4 | $93.5M | Buy |
+1,381,790
| New | +$93.5M | 0.04% | 378 |
|
|
2022
Q1 | – | Sell |
-113,654
| Closed | -$6.37M | – | 3317 |
|
|
2021
Q4 | $6.37M | Sell |
113,654
-27,254
| -19% | -$1.53M | ﹤0.01% | 1973 |
|
|
2021
Q3 | $6.76M | Sell |
140,908
-6
| -0% | -$288 | ﹤0.01% | 2055 |
|
|
2021
Q2 | $5.9M | Hold |
140,914
| – | – | ﹤0.01% | 2164 |
|
|
2021
Q1 | $4.75M | Buy |
140,914
+646
| +0.5% | +$21.8K | ﹤0.01% | 2197 |
|
|
2020
Q4 | $4.9M | Sell |
140,268
-362
| -0.3% | -$12.6K | ﹤0.01% | 2089 |
|
|
2020
Q3 | $4.88M | Sell |
140,630
-434
| -0.3% | -$15.1K | ﹤0.01% | 1925 |
|
|
2020
Q2 | $4.62M | Sell |
141,064
-538
| -0.4% | -$17.6K | ﹤0.01% | 1937 |
|
|
2020
Q1 | $4.26M | Sell |
141,602
-272
| -0.2% | -$8.19K | ﹤0.01% | 1804 |
|
|
2019
Q4 | $4.11M | Buy |
+141,874
| New | +$4.11M | ﹤0.01% | 2093 |
|